MedTrace Logo

Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy.

NCT03496064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-02-27

No results posted yet for this study

Summary

The Bernese-European RegistrY for ischemic stroke patients treated Outside current guidelines with Neurothrombectomy Devices using the SOLITAIRE™ FR With the Intention For Thrombectomy (BEYOND-SWIFT) is a retrospective, multi-center, non-randomized observational study aims to investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device (applied as initial devices used for intervention) in acute ischemic stroke patients who do not fulfill treatment eligibility according to current guidelines. Patients will be treated or were treated at the discretion of the investigator, independent of participation in this registry. Primary Analysis is the Impact of successful reperfusion on functional outcome at day 90 in patients presenting with large infarct cores (ASPECTS\<6) or minor symptoms (NIHSS\<8).

Conditions

Interventions

OTHER

Successful reperfusion

Defined as modified Thrombolysis in Cerebral Infarction 2b/3

Sponsors & Collaborators

  • University Hospital, Toulouse

    collaborator OTHER

  • Technical University of Munich

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Medtronic

    collaborator INDUSTRY

  • CHU de Reims

    collaborator OTHER

  • Hospital Vall d'Hebron

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Urs Fischer, MD, MSc · Department of Neurology, University Hospital Bern, Switzerland

  • Jan Gralla, MD · Department of Neuroradiology, University Hospital Bern, Switzerland

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-04-15
Completion
2018-12-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03496064 on ClinicalTrials.gov